NasdaqCM - Nasdaq Real Time Price USD

COSCIENS Biopharma Inc. (CSCI)

3.5500
+0.2400
+(7.25%)
At close: May 9 at 4:00:00 PM EDT
3.5600
+0.01
+(0.28%)
After hours: May 9 at 4:05:12 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
9,587
9,587
7,143
14,572
13,486.3210
Cost of Revenue
4,858
4,858
4,205
6,016
5,276.5439
Gross Profit
4,729
4,729
2,938
8,556
8,209.7771
Operating Expense
18,752
18,752
7,567
4,236
5,619.5495
Operating Income
-14,023
-14,023
-4,629
4,320
2,590.2276
Net Non Operating Interest Income Expense
312
312
-77
2
-162.2649
Other Income Expense
-1,514
-1,514
336
206
158.6493
Pretax Income
-15,225
-15,225
-4,370
4,528
2,586.6120
Tax Provision
84
84
-885
1,080
-52.9192
Net Income Common Stockholders
-15,309
-15,309
-3,485
3,448
2,639.5311
Diluted NI Available to Com Stockholders
-15,309
-15,309
-3,485
3,448
2,639.5311
Basic EPS
-4.46
-5.93
-1.89
1.87
1.33
Diluted EPS
-4.46
-5.93
-1.89
1.86
1.33
Basic Average Shares
2,258.1260
2,581.3080
1,847.2330
1,839.8960
1,833.1010
Diluted Average Shares
2,258.1260
2,581.3080
1,847.2330
1,854.5370
1,854.7400
Total Operating Income as Reported
-18,280
-18,280
-4,629
4,320
2,427.9627
Total Expenses
23,610
23,610
11,772
10,252
10,896.0934
Net Income from Continuing & Discontinued Operation
-15,309
-15,309
-3,485
3,448
2,639.5311
Normalized Income
-13,938.8000
-13,938.8000
-3,465.8604
3,287.3269
2,680.3694
Interest Income
441
441
59
145
--
Interest Expense
129
129
136
143
119.1283
Net Interest Income
312
312
-77
2
-162.2649
EBIT
-15,096
-15,096
-4,234
4,671
2,705.7403
EBITDA
-13,489
-13,489
-2,791
6,139
4,180.8136
Reconciled Cost of Revenue
4,858
4,858
4,205
6,016
5,276.5439
Reconciled Depreciation
1,607
1,607
1,443
1,468
1,475.0733
Net Income from Continuing Operation Net Minority Interest
-15,309
-15,309
-3,485
3,448
2,639.5311
Total Unusual Items Excluding Goodwill
-1,612
-1,612
-24
211
-55.5623
Total Unusual Items
-1,612
-1,612
-24
211
-55.5623
Normalized EBITDA
-11,877
-11,877
-2,767
5,928
4,236.3759
Tax Rate for Calcs
0.0002
0.0002
0.0002
0.0002
0.0003
Tax Effect of Unusual Items
-241.8000
-241.8000
-4.8604
50.3269
-14.7240
12/31/2021 - 5/10/2000

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

SQZB SQZ Biotechnologies Company
0.0280
0.00%
 
ENZN Enzon Pharmaceuticals, Inc.
0.0900
0.00%
 
APLI.TO Appili Therapeutics Inc.
0.0300
-14.29%
 
TTNP Titan Pharmaceuticals, Inc.
5.09
-3.60%
 
TENX Tenax Therapeutics, Inc.
5.57
-2.02%
 
MSCLF Satellos Bioscience Inc.
0.4820
0.00%
 
FNCH Finch Therapeutics Group, Inc.
13.50
+4.25%
 
OTLC Oncotelic Therapeutics, Inc.
0.0600
+2.21%
 
VTVT vTv Therapeutics Inc.
20.80
-2.12%
 
GLYC GlycoMimetics, Inc.
0.2402
-0.95%